|Day Low/High||7.38 / 7.70|
|52 Wk Low/High||6.07 / 25.00|
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present more than 30 analyses on fremanezumab, at the 19 th Congress of the International Headache Society (IHC), taking place in Dublin, Ireland on September 5-8,...
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
U.S. stock futures rise modestly on Tuesday as investors are cautiously optimistic a trade deal between Washington and Beijing can be reached; Johnson & Johnson is found responsible for helping fuel the opioid crisis in Oklahome and is ordered to pay $572 million; Russian conglomerate Rostec confirms it filed a lawsuit in the United States to cancel its order for Boeing 737 MAX jets, a report says.
Jim Cramer takes a look at Union Pacific, Pfizer, Merck, AbbVie, Teva Pharmaceuticals, ABM Industries, Schlumberger and more.
Antares Pharma and Encana are on our radar today.
Teva says patients taking Ajovy experienced a significant reduction in migraine days compared to those receiving placebos.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four...
Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.
NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd.
There has been an EpiPen shortage in the U.S., Europe and Canada, thanks to manufacturing delays at Pfizer.
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr® 1 (epinephrine injection, USP) Auto-Injector, 0.
Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
It's a process that involves harvesting gains by repeatedly writing call options against stocks steadily in decline.
Stocks fell sharply before ending mixed Wednesday, as investors grappled with the U.S.-China trade war.
Teva Pharmaceutical posted stronger-than-expected second quarter earnings Wednesday, and reiterated its full-year profit guidance, as new generic drug launches in north America boosted revenue growth.
The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.
U.S. stock futures rise Wednesday but trading is cautious amid concerns the U.S.-China trade dispute could spiral into a currency war; Disney's fiscal third-quarter earnings and revenue miss analysts' expectations; CVS Health and Lyft to report earnings.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Michael (Mike) McClellan, Executive Vice President and Chief Financial Officer ("CFO"), has decided to step down from his role as CFO due to personal reasons requiring him to...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2019.
AbbVie and Bristol-Myers Squibb are two pharmaceutical giants where insiders have snatched up big blocks of stock.
While you may think earnings season is winding down, we still got quite a bit left to go ... here are key companies to keep an eye on the week of August 5, 2019.
Shares of Teva Pharmaceuticals fall after the company receives a downgrade from Morgan Stanley amid heightened "litigation risks" related to its involvement in the opioid crisis.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.
Studying the indicators shows we’re overbought and still complacent, but still some charts deserve special focus, like insider selling, the McClellan Summation Index and small caps.
Teva Pharmaceuticals USA, Inc. today announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.